[1]
“Expert Consensus. Optimization of the anti-VEGF treatment regimens with aflibercept in patients with neovascular age-related macular degeneration and visual impairment as a result of diabetic macular edema”, J.ophthalmol. (Ukraine), no. 5, pp. 64–67, Dec. 2025.